Fresh analysis suggests that patients who discontinue new slimming jabs like Wegovy and Mounjaro can put back on shed pounds much more quickly than those who halt traditional diet and exercise programs.
Research printed in a leading health publication points out that while overweight individuals can lose substantial amounts of their total mass while undergoing treatment, the weight returns at an estimated rate of nearly a kilo each month upon discontinuation.
"Users purchasing such medications need to be cognizant of the risk of rapid weight regain when the therapy is stopped," stated expert Dr. Susan Jebb.
Such speed of regain implies a return to original mass in about one and a half years.
Comparing Approaches
The study, which looked at 37 of trials involving over 9,000 of participants, compared the outcomes of the injectable medications with other pills.
Scientists note that individuals who shed pounds through lifestyle changes alone typically experience a slower creep back—approximately 100 grams monthly—after stopping.
Understanding the Rapid Rebound
Doctors believe the way of the jabs accounts for the accelerated regain.
These medications mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Long-term administration of GLP-1 levels far above than the body's typical production might result in the system to produce less of its endogenous hormone, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' means appetite is uncontrolled, making binge eating far more likely."
An Ongoing Issue?
Medical guidelines advise the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians argue that, considering the high risk of weight regain, the treatment is often ongoing.
This opinion is echoed by pharmaceutical companies, who say that the results "emphasize the persistent character of obesity," akin to managing diseases like hypertension.
User Testimonies
People who have discontinued the medication describe a powerful return of appetite.
"It felt as if something activating and you become extremely hungry," said an individual.
The struggle is exacerbated if patients have not developed sustainable dietary or behavioural modifications during treatment.
Significant Use
Survey data show that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand remaining high.
- Use is higher among females than males.
- The 40s and 50s demographic shows the highest level of interest.
- A large proportion obtain the medications through private prescriptions rather than public health services.
Finally, researchers emphasize that while GLP-1 drugs are powerful agents for weight loss, they are not a magic fix and long-term success hinges on integrated lifestyle changes.
